SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15

M. Tessema, C. M. Yingling, C. L. Thomas, D. M. Klinge, A. M. Bernauer, Y. Liu, S. Dacic, J. M. Siegfried, S. E. Dahlberg, J. H. Schiller, S. A. Belinsky

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint Dive into the research topics of 'SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15'. Together they form a unique fingerprint.

Medicine & Life Sciences